Skip to content
The Nexus
HEALTHJun 29 · 18:53 UTCCNBC TOP

Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities

Eli Lilly and Regeneron are among the first seven companies selected by the FDA for its PreCheck Pilot Program, an initiative aimed at accelerating the review of new manufacturing facilities. The program was reported by CNBC.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Eli LillyorganizationRegeneronorganizationFDAorganizationPreCheck Pilot ProgramtopicCNBCorganization
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting